Dipexium Pharmaceuticals (DPRX) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts DPRX Hot Sheet
Join SI Premium – FREE
Dipexium Pharmaceuticals (NASDAQ: DPRX) reported Q2 EPS of ($0.47), $0.04 worse than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Dipexium Pharmaceuticals (DPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
